Literature DB >> 19786295

Combined cis-regulator elements as important mechanism affecting FXII plasma levels.

Maria Sabater-Lleal1, Miguel Chillón, Carolina Mordillo, Angel Martínez, Estel Gil, José Mateo, John Blangero, Laura Almasy, Jordi Fontcuberta, José Manuel Soria.   

Abstract

INTRODUCTION: Factor XII (FXII) deficiency is a recessive Mendelian trait due to mutations in the F12 gene. There is no bleeding associated with FXII deficiency, but FXII deficiency has been reported to be associated with risk of thrombosis in some studies.
MATERIAL AND METHODS: We examined the functional effect of two naturally-occurring mutations in two Spanish FXII deficient families: a C/G substitution at position -8, and a C/T substitution at position -13. Both mutations were located on a putative HNF4 binding site of F12 gene promoter. We also analyzed the F12 C46T polymorphism (rs1801020), associated with a decrease in the FXII levels, which also segregated in both families. A fragment containing each one of both -8 and -13 mutations, was cloned 5' of a reporter gene. We compared the in vitro expression of these constructs to the wild type expression.
RESULTS: Our analyses confirm that the -8C/G and the -13C/T mutations decreased expression levels, demonstrating that both mutations are involved in the observed FXII deficiency. In addition, electrophoretic shift analyses suggest that they alter the union of nuclear proteins to the promoter. Coinheritance of these mutations with the C46T polymorphism, result in a significant genotype-phenotype correlation.
CONCLUSIONS: We have identified two naturally-occurring mutations in the F12 promoter that drastically reduce FXII levels. Knowing rare genetic alterations in the F12 gene, together with the C46T common variant, may yield further understanding about the genetic architecture of FXII levels, which may have a role in the risk of thrombosis. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19786295      PMCID: PMC2906145          DOI: 10.1016/j.thromres.2009.08.019

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  30 in total

1.  Nomenclature for the description of human sequence variations.

Authors:  J T den Dunnen; S E Antonarakis
Journal:  Hum Genet       Date:  2001-07       Impact factor: 4.132

2.  A quantitative-trait locus in the human factor XII gene influences both plasma factor XII levels and susceptibility to thrombotic disease.

Authors:  José Manuel Soria; Laura Almasy; Juan Carlos Souto; Delphine Bacq; Alfonso Buil; Alexandra Faure; Elisabeth Martínez-Marchán; José Mateo; Montserrat Borrell; William Stone; Mark Lathrop; Jordi Fontcuberta; John Blangero
Journal:  Am J Hum Genet       Date:  2002-01-22       Impact factor: 11.025

3.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

4.  A common C-->T polymorphism at nt 46 in the promoter region of coagulation factor XII is associated with decreased factor XII activity.

Authors:  G Endler; M Exner; C Mannhalter; S Meier; K Ruzicka; S Handler; S Panzer; O Wagner; P Quehenberger
Journal:  Thromb Res       Date:  2001-02-15       Impact factor: 3.944

5.  Functional quantification of cyclosporine A and FK506 in human whole blood by flow cytometry, using the green fluorescent protein as an interleukin-2 reporter gene.

Authors:  J L Taupin; P Merville; T McBride; L Potaux; J F Moreau
Journal:  J Immunol Methods       Date:  2001-10-01       Impact factor: 2.303

6.  Homozygosity of the T allele of the 46 C->T polymorphism in the F12 gene is a risk factor for ischemic stroke in the Spanish population.

Authors:  Amparo Santamaría; José Mateo; Isabel Tirado; Arturo Oliver; Roberto Belvís; Joan Martí-Fábregas; Rosa Felices; José Manuel Soria; Juan Carlos Souto; Jordi Fontcuberta
Journal:  Stroke       Date:  2004-07-01       Impact factor: 7.914

Review 7.  The epidemiology of venous thromboembolism.

Authors:  Richard H White
Journal:  Circulation       Date:  2003-06-17       Impact factor: 29.690

Review 8.  Risk factors for venous thromboembolism.

Authors:  Frederick A Anderson; Frederick A Spencer
Journal:  Circulation       Date:  2003-06-17       Impact factor: 29.690

9.  Role of high-molecular-weight kininogen in surface-binding and activation of coagulation Factor XI and prekallikrein.

Authors:  R C Wiggins; B N Bouma; C G Cochrane; J H Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

10.  Role of surface in surface-dependent activation of Hageman factor (blood coagulation factor XII).

Authors:  J H Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  1978-04       Impact factor: 11.205

View more
  3 in total

Review 1.  Factor XII: what does it contribute to our understanding of the physiology and pathophysiology of hemostasis & thrombosis.

Authors:  Evi Stavrou; Alvin H Schmaier
Journal:  Thromb Res       Date:  2010-03       Impact factor: 3.944

2.  The FXII c.-4T>C Polymorphism as a Disease Modifier in Patients With Hereditary Angioedema Due to the FXII p.Thr328Lys Variant.

Authors:  Fernando Corvillo; María Eugenia de la Morena-Barrio; Carmen Marcos-Bravo; Margarita López-Trascasa; Vicente Vicente; Jonas Emsley; Teresa Caballero; Javier Corral; Alberto López-Lera
Journal:  Front Genet       Date:  2020-09-10       Impact factor: 4.599

3.  Why do we want to know how factor XII levels are modulated?

Authors:  Alvin H Schmaier
Journal:  Thromb Res       Date:  2009-10-21       Impact factor: 3.944

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.